TheraDiag SA (ALTER):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C11478)
◆英語タイトル:TheraDiag SA (ALTER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11478
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA (ALTER) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TheraDiag SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9
TheraDiag SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TheraDiag SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 11
Equity Offering 12
TheraDiag Raises USD4.5 Million in Private Placement of Shares 12
TheraDiag Raises USD2.78 Million in Private Placement of Shares 13
TheraDiag Raises Funds in IPO of Shares 14
Acquisition 15
Theradiag Acquires Prestizia, Developer Of microRNA Technology 15
TheraDiag SA – Key Competitors 16
TheraDiag SA – Key Employees 17
TheraDiag SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 19
Financial Announcements 20
Sep 19, 2018: Theradiag: 2018 interim results and business update 20
Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 22
Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 24
Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 25
Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 26
Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 28
Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 29
Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 30
Mar 01, 2017: THERADIAG: Full-year 2016 results 31
Corporate Communications 33
Oct 09, 2018: Evolution of Theradiag’s governance 33
Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag’s Board of Directors 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
TheraDiag SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TheraDiag SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TheraDiag SA, Deals By Therapy Area, 2012 to YTD 2018 8
TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9
TheraDiag SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 11
TheraDiag Raises USD4.5 Million in Private Placement of Shares 12
TheraDiag Raises USD2.78 Million in Private Placement of Shares 13
TheraDiag Raises Funds in IPO of Shares 14
Theradiag Acquires Prestizia, Developer Of microRNA Technology 15
TheraDiag SA, Key Competitors 16
TheraDiag SA, Key Employees 17
TheraDiag SA, Subsidiaries 18

List of Figures
TheraDiag SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TheraDiag SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ TheraDiag SA (ALTER):製薬・医療:M&Aディール及び事業提携情報(TheraDiag SA (ALTER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆